Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

Human anti-cancer drugs could help Tasmanian devils
Tasmanian devils are considered endangered as a result of devil facial tumour 1.
RTKs have ‘an important role’ in sustaining transmissible cancers

Key drugs used to treat cancer in humans may also be useful in the fight against transmissible cancers in Tasmanian devils.

This is according to a new study by the University of Cambridge, which found that certain drugs used in humans were able to efficiently stop the growth of devil cancer cells in the lab.

The research, published in the journal Cancer Cell, shows that molecules known as receptor tyrosine kinases (RTKs) have an important role to play in sustaining the growth and survival of transmissible cancers in devils. Drugs targeting RTKs have already been developed for human cancers.

Tasmanian devils are considered endangered as a result of devil facial tumour 1 (DFT1), which is passed between animals through biting and causes disfiguring facial tumours. Usually fatal, DFT1 has spread throughout Tasmania since it was first seen in 1996, causing significant declines in devil populations.

Routine diagnostic screening in 2014 uncovered a second transmissible cancer in the species. With the naked eye, facial tumours caused by devil facial tumour 2 (DFT2) cannot be distinguished from those caused by DFT1, but analysis has shown they differ at a biological level.

Cambridge researchers found striking similarities between the two cancer types; in terms of genetics, tissues of origin, the way in which the cancer cells mutate and possible drug targets.

First author Dr Elizabeth Murchison said: “The story of Tasmanian devils in recent years has been a very concerning one. This study gives us optimism that anti-cancer drugs that are already in use in humans may offer a chance to assist with conservation efforts for this iconic animal.”

Become a member or log in to add this story to your CPD history

Vets save premature penguin chick

News Story 1
 Vets have saved a tiny Humboldt penguin chick after her egg was accidentally broken by her parents. Keepers at ZSL London Zoo were shocked to find the chick, named Rainbow, still alive and rushed her straight to the Zoo’s on-site veterinary clinic.

It was a little way to go until the chick should have hatched, so the process was touch and go. Vets removed bits of shell from around the chick with tweezers until she could be lifted out and placed in a makeshift nest.

Rainbow is now in a custom-built incubation room where she spends her days cuddled up to a toy penguin. Keepers will hand-fed Rainbow for the next 10 weeks until she is healthy enough to move to the penguin nursery.  

Click here for more...
News Shorts
BVA infographic to help shoppers understand farm assurance schemes

An infographic to help members of the public understand farm assurance schemes has been produced by the BVA. The infographic outlines BVA’s priorities for animal welfare and shows whether or not the schemes address these priorities in their standards.

BVA president John Fishwick said: “The infographic is not intended to be a league table but to allow people to understand what aspects of animal health and welfare are addressed by assurance schemes so that they can decide which scheme best aligns with their own individual preferences and priorities."